1.60
price up icon5.26%   0.08
 
loading
Biovie Inc stock is traded at $1.60, with a volume of 187.05K. It is up +5.26% in the last 24 hours and down -80.46% over the past month. BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.52
Open:
$1.54
24h Volume:
187.05K
Relative Volume:
0.76
Market Cap:
$13.08M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-0.3077
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
-3.03%
1M Performance:
-80.46%
6M Performance:
+8.11%
1Y Performance:
-52.10%
1-Day Range:
Value
$1.52
$1.6475
1-Week Range:
Value
$1.46
$1.80
52-Week Range:
Value
$0.62
$9.56

Biovie Inc Stock (BIVI) Company Profile

Name
Name
Biovie Inc
Name
Phone
775-888-3162
Name
Address
680 W NYE LANE, CARSON CITY
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
BIVI's Discussions on Twitter

Compare BIVI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
BIVI
Biovie Inc
1.60 13.08M 0 -25.56M -19.35M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-22 Initiated Cantor Fitzgerald Overweight
Jan-15-21 Initiated B. Riley Securities Buy

Biovie Inc Stock (BIVI) Latest News

pulisher
Aug 20, 2025

BioVie stock dips on pricing $12M securities offering - MSN

Aug 20, 2025
pulisher
Aug 19, 2025

New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - Amarillo Globe-News

Aug 19, 2025
pulisher
Aug 16, 2025

What hedge funds are buying BioVie Inc.Weekly Trade Recap & Real-Time Market Sentiment Reports - mustnews.co.kr

Aug 16, 2025
pulisher
Aug 15, 2025

Why Is BioVie Stock (BIVI) Down 50% Today? - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

Can BioVie Inc. deliver alphaJuly 2025 Drop Watch & AI Driven Price Predictions - newsimpact.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Will BioVie Inc. announce a stock split2025 Volatility Report & Stepwise Trade Signal Guides - thegnnews.com

Aug 15, 2025
pulisher
Aug 14, 2025

How high can BioVie Inc. stock price go in 2025Earnings Trend Report & Weekly High Conviction Ideas - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Smart tools for monitoring BioVie Inc.’s price action2025 Fundamental Recap & Accurate Trade Setup Notifications - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Understanding BioVie Inc.’s price movementTake Profit & Long-Term Capital Growth Strategies - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

BioVie Inc. Presents Phase 2 ADDRESS-LC Trial Design for Bezisterim in Long COVID at Keystone Symposia - Quiver Quantitative

Aug 13, 2025
pulisher
Aug 13, 2025

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design - GlobeNewswire

Aug 13, 2025
pulisher
Aug 13, 2025

BioVie's Novel Long COVID Drug Trial Targets Brain Fog and Fatigue in 18M+ Americans - Stock Titan

Aug 13, 2025
pulisher
Aug 12, 2025

BioVie Completes $10.4 Million Public Offering - The Globe and Mail

Aug 12, 2025
pulisher
Aug 12, 2025

BioVie Inc. stock prediction for this weekAI Trend Detection for Entry Timing - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Sector ETF performance correlation with BioVie Inc.Entry and Exit Strategy for Swing Traders - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

BioVie Completes $10.4 Million Public Offering to Strengthen Financial Position - AInvest

Aug 12, 2025
pulisher
Aug 11, 2025

Has BioVie Inc. found a price floorPortfolio Risk Distribution Analysis Tool - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

BioVie closes $12 million public offering of units By Investing.com - Investing.com Canada

Aug 11, 2025
pulisher
Aug 11, 2025

BioVie Inc. Announces Closing of $12 Million Public Offering - GlobeNewswire

Aug 11, 2025
pulisher
Aug 11, 2025

BioVie Inc. Raises $12 Million Through Public Offering - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline - Stock Titan

Aug 11, 2025
pulisher
Aug 11, 2025

What machine learning models say about BioVie Inc.Real-Time Setup Summary with ROI Focus - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Why BioVie Inc. stock is on top investor watchlistsReal-Time Investment Picks with Accuracy - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

BioVie closes $12 million public offering of units - Investing.com

Aug 11, 2025
pulisher
Aug 10, 2025

What is the short-term price target for BIVI according to analyst ratings? - AInvest

Aug 10, 2025
pulisher
Aug 09, 2025

Bloomberg to Air New to The Street Episode #683 Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

BioVie Inc. Raises $12 Million in Public Offering, Offers Warrants - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

BioVie Prices 6M Share Secondary at $2.00, Below Last Closing Price of $2.91 - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewswire

Aug 08, 2025
pulisher
Aug 08, 2025

BioVie (BIVI.O) Crashes 42.78%: What's Behind the Sharp Intraday Move? - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Biovie stock plunges after pricing $12 million public offering By Investing.com - Investing.com South Africa

Aug 08, 2025
pulisher
Aug 08, 2025

Biovie stock plunges after pricing $12 million public offering - Investing.com

Aug 08, 2025
pulisher
Aug 08, 2025

S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results - Benzinga

Aug 08, 2025
pulisher
Aug 08, 2025

BioVie's 45% Plunge: A Capital Raise Gone Wrong? - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

US Stocks Surge as Dow Gains 300 Points, American Axle & Mfg Posts Upbeat Earnings - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Dow Surges 300 Points; American Axle & Manufacturing Posts Upbeat Earnings - Benzinga

Aug 08, 2025
pulisher
Aug 08, 2025

BioVie Announces $12M Securities Offering - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

BioVie's (BIVI) 43% Plunge: A Volatile Turn in the Biotech Arena? - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

BioVie Stock Dips After Share Offering News - timothysykes.com

Aug 08, 2025
pulisher
Aug 08, 2025

Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 08, 2025
pulisher
Aug 08, 2025

Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed - Stock Titan

Aug 08, 2025
pulisher
Aug 08, 2025

BioVie prices $12 million public offering of units at $2.00 each - Investing.com

Aug 08, 2025
pulisher
Aug 07, 2025

Biovie's $12M Equity Raise: Is This a Strategic Lifeline or a Warning Signal for Small-Cap Biotechs? - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

BioVie Inc. Raises $12 Million in Public Offering - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Biovie announces pricing of $12 million public offering - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Biovie Announces Pricing Of $12 Million Public Offering - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

BioVie Inc. Announces Pricing of $12 Million Public Offering - Benzinga

Aug 07, 2025
pulisher
Aug 07, 2025

Real time scanner hits for BioVie Inc. explainedTrading Volume Anomaly Summary and Insight - Newser

Aug 07, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in BioVie Inc. stockHigh-velocity gains - Jammu Links News

Aug 03, 2025

Biovie Inc Stock (BIVI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):